Sheng-Qiong Deng1&*, Xian-Tao Zeng2&,

Sheng-Qiong Deng,Xian-Tao Zeng,Yun Wang,Qing Ke,Qiong-Li Xu

2013-01-01

Abstract:The cytochromes P450 (CYPs) gene polymorphisms played an important role in the development of various cancers (Jin et al., 2011; Leng et al., 2012; Niu et al., 2012). Cytochrome P450 1A2 (CYP1A2) is one enzyme of the CYPs and it is a key enzyme in the activation of major classes of indirect carcinogens (Boobis et al., 1994). CYP1A2 gene has been mapped on chromosome 15q24.1 and is highly polymorphic (Zhou et al., 2009). According to NCBI dbSNP database, there are more than 200 polymorphisms existed in CYP1A2 gene region. CYP1A2 -163 C>A polymorphism (CYP1A2*1F; rs762551) is located in the intron1 of CYP1A2 (Sachse et al., 1999), there are many studies focused on this polymorphism and risk of cancer have been published (Wang et al., 2012). In 2012, a meta-analysis by Wang et al (Wang et al., 2012) identified 19 eligible case control studies on the association between CYP1A2 -163 C>A polymorphism and risk of cancer, which suggested that CYP1A2 -163 C>A polymorphism is likely to be associated with susceptibility to cancer in Caucasians. Lung cancer is one of the six different cancers in this meta-analysis; however, there are histopathological types of lung cancer